MTOR and breast cancer: However, in our breast cancer model, we observed increased p-AMPK levels associated with increased p-mTOR and pro-inflammatory signaling in the TME in RD-fed mice and HFD-fed mice at an early time point of tumorigenesis and at a late time point of tumor progression, respectively (Figure 5).